Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany
Jan Zeidler(Leibniz University Hannover), Stephan Heres(München Klinik), Wolfgang Greiner(Bielefeld University), Jörg Mahlich(University of Vienna)
Cited by 31
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
|The Lancet|2012|923
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476